CtDNA Levels Before, During Treatment Can Predict How A Patient With DLBCL Will Respond To Standard Therapy, Research Indicates.

September 05, 2018

Cancer Therapy Advisor (9/4, Bennett) reports that research indicates “circulating tumor DNA (ctDNA) levels before and during treatment can predict how a patient with diffuse large B-cell lymphoma (DLBCL) responds to standard therapy.” The research “sugg...

Chat With ASCP

First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Name *
Country Code *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

The American Society for Clinical Pathology (ASCP) is a professional association based in Chicago, Illinois encompassing 100,000 pathologists and laboratory professionals. Founded in 1922, ASCP provides programs in education, certification and advocacy on behalf of patients, pathologists and laboratory professionals.

Chat with us

Request a call

Connect with us

33 West Monroe Street, Suite 1600
Chicago, IL 60603